Disposition of 882 shares by John Kim of Cognizant Technology subject to Rule 16b-3
| 950130 Stock | KRW 5,520 30.00 0.55% |
About 53% of Access Bio's investor base is interested to short. The analysis of current outlook of investing in Access Bio suggests that many traders are impartial regarding Access Bio's prospects. The current market sentiment, together with Access Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Access Bio stock news signals to limit their universe of possible portfolio assets.
Access |
Filed transaction by Cognizant Technology Solutions Officer: Evp, Clo, Cao. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Access Bio Fundamental Analysis
We analyze Access Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Access Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Access Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Access Bio is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Access Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Access Bio stock to make a market-neutral strategy. Peer analysis of Access Bio could also be used in its relative valuation, which is a method of valuing Access Bio by comparing valuation metrics with similar companies.
Peers
Access Bio Related Equities
| 248170 | Sempio Foods | 0.56 |
| ||
| 004590 | Hankook Furniture | 0.59 |
| ||
| 003230 | Samyang Foods | 2.71 |
| ||
| 003230 | Sam Yang | 2.71 |
| ||
| 286940 | Lotte Data | 3.37 |
| ||
| 073490 | Innowireless | 3.61 |
| ||
| 041020 | Polaris Office | 6.35 |
| ||
| 051910 | LG Chemicals | 6.57 |
|
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |